Abstract
Local anesthetics are the pharmacologic cornerstone of regional anesthesia producing reversible and complete blockade of neuronal transmission when applied near the axons. Development of local anesthetics, since the 1950s, has focused on amide local anesthetics. Ester local anesthetics exhibit a number of limitations including instability when in solution, short shelf life, degradation when exposed to high temperatures, and an increased propensity to cause allergic reactions. Local anesthetics are widely used to prevent or treat acute pain; to treat inflammatory, cancer, and chronic pain; and for diagnostic and prognostic purposes. Nociceptive pain, as well as neuropathic pain, is targeted with this group of drugs. Any part of the nervous system, from the periphery to the brain, may be where local anesthetics act to produce a desired anesthetic or analgesic effect.
This chapter describes the basic chemical structure of local anesthetics, and gives an overview of pharmacologic properties of the different drugs. Clinical use, advantages, and side effects are compared, and local anesthetic toxicity is described.
References
Lee-Son S, Wang GK, Concus A, Crill E, Strichartz G. Stereoselective inhibition of neuronal sodium channels by local anesthetics. Evidence for two sites of action? Anesthesiology. 1992;77(2):324–35.
Mulroy MF, Bernards CM. A practical approach to regional anesthesia. 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2009.
Creative Commons Attribution 4.0 International License from OpenStax. Anatomy & physiology. Houston: OpenStax, Rice University; 2016.
Butterworth JFT, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 1990;72(4):711–34.
Tetzlaff JE. Clinical pharmacology of local anesthetics. Boston: Butterworth-Heinemann; 2000.
Datta S, Kodali BS, Segal S. Ch 2. Local anesthetic pharmacology. In: Obstetric anesthesia handbook. 5th ed. New York: Springer Science + Business Media; 2010.
Mossetti V, Vicchio N, Ivani G. Local anesthetics and adjuvants in pediatric regional anesthesia. Curr Drug Targets. 2012;13(7):952–60.
Patel N, Sadoughi A. Ch 11. Pharmacology of local anesthetics. In: Kaye AD, editor. Essentials of pharmacology for anesthesia, pain medicine, and critical care. New York: Springer Science and Business Media; 2015.
Groban L, Butterworth J. Lipid reversal of bupivacaine toxicity: has the silver bullet been identified? Reg Anesth Pain Med. 2003;28(3):167–9.
Neal JM, Bernards CM, Butterworth JF, Di Gregorio G, Drasner K, Hejtmanek MR, et al. ASRA practice advisory on local anesthetic toxicity. Special Article. Reg Anesth Pain Med. 2010;35:152–61.
Di Gregorio G, Schwartz D, Ripper R, Kelly K, Feinstein DL, Minshall RD, et al. Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest. Crit Care Med. 2009;37:993–9.
Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med. 2012;37(1):16–8.
Silvanto M, Tarkkila P, Makela ML, Rosenberg PH. The influence of ambulation time on the incidence of transient neurologic symptoms after lidocaine spinal anesthesia. Anesth Analg. 2004;98(3):642–6.
Faccenda KA, Finucane BT. Complications of regional anaesthesia incidence and prevention. Drug Saf. 2001;24:413–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Elsharkawy, H., Kolli, S. (2018). Pharmacology of Local and Neuraxial Anesthetics. In: Farag, E., Argalious, M., Tetzlaff, J.E., Sharma, D. (eds) Basic Sciences in Anesthesia. Springer, Cham. https://doi.org/10.1007/978-3-319-62067-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-62067-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62065-7
Online ISBN: 978-3-319-62067-1
eBook Packages: MedicineMedicine (R0)